Skip to main content
Explore URMC

URMC Logo

William M. Maniscalco, M.D.

Pediatrics

Clinical Interests

Neonatology; NICU Continuing Care

Contact Information

Phone Numbers

Office: (585) 275-5884

Fax: (585) 461-3614

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Biography

Bronchopulmonary Dysplasia

Research

Dr. Maniscalco studies pulmonary microvascular development in lung injury. Using various animal models, including a non-human primate model of BPD, this work examines the effects of oxygen and ventilation of immature lung on the development of alveolar capillaries. The major goals of the research are to characterize microvascular development in lung injury and investigate angiogenic and angiostatic regulators in normal and injured lung. Recent work has linked expression of inflammatory CXC chemokine mediators, which regulate angiogenesis and are part of the pathophysiology of BPD, to impaired lung microangiogenesis.

Credentials

Faculty Appointments

Specialties

  • Neonatal-Perinatal Medicine - American Board of Pediatrics
  • Pediatrics - American Board of Pediatrics

Education

1968
BA | University of Massachusetts
Pre-Medical

1972
MD | Johns Hopkins University School of Medicine
Medicine

Post-doctoral Training & Residency

07/01/1972 - 06/30/1973
Internship in Pediatrics at Children's Hospital Boston

07/01/1973 - 06/30/1975
Residency in Pediatrics at Children's Hospital Boston

07/01/1975 - 06/30/1978
Fellowship in Pediatrics: Neonatal-Perinatal Medicine at Yale New Haven Hospital

VIEW ALL expand_more

Awards

2016
America's Top Doctors
Sponsor: Castle Connolly Medical, Ltd.

1980 - 1982
Buswell Faculty Research Award
Sponsor: University of Rochester School of Medicine
Location: Rochester, NY

Publications

Journal Articles

2009
McCurnin, DC.; Willis, B.; Pierce, RA.; Chang, Ly.; Yoder, BA.; Yuhanna, IS.; Ballard, PA.; Pepe, JK.; Maniscalco, WM.; Crapo, JD.; Grubb, PH.; Shaul, PW. "Postnatal estradiol administration upregulates pulmonary NO synthase, improves pulmonary function, and lowers ventilatory support requirements in a primate model of neonatal chronic lung disease of Prematurity." Am J Respir Crit Care Med. 2009; .

6/2007
Pierce RA, Joyce B, Officer S, Heintz C, Moore C, McCurnin D, Johnston C, Maniscalco W. "Retinoids increase lung elastin expression but fail to alter morphology or angiogenesis genes in premature ventilated baboons." Pediatric research.. 2007 Jun 0; 61(6):703-9.

11/2006
Yee M, Vitiello PF, Roper JM, Staversky RJ, Wright TW, McGrath-Morrow SA, Maniscalco WM, Finkelstein JN, O'Reilly MA. "Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung development." American journal of physiology. Lung cellular and molecular physiology.. 2006 Nov 0; 291(5):L1101-11. Epub 2006 Jul 21.

Books & Chapters

2009
Chapter Title: Disruption of Lung Vascular Development in BPD
Book Title: Informa Healthcare
Author List: Maniscalco, WM.; Bhandari, V.
Published By: Abman (In Press)2009 in New York

2006
Chapter Title: Vascular endothelial growth factor.
Book Title: Encyclopedia of Respiratory Medicine
Author List: D'Angio CT, Maniscalco WM
Edited By: Laurent GJ, Shapiro SD
Published By: Elsevier2006 in London, England

2006
Chapter Title: Vascular endothelial growth factor.
Book Title: Encyclopedia of Respiratory Medicine
Author List: D'Angio CT, Maniscalco WM
Edited By: Laurent GJ, Shapiro SD
Published By: Elsevier2006 in London, England

VIEW ALL PUBLICATIONS